vimarsana.com
Home
Live Updates
177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs : vimarsana.com
177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs
Lutetium Lu 177 dotatate plus octreotide significantly improved PFS vs high-dose octreotide in patients with gastroenteropancreatic neuroendocrine tumors.
Related Keywords
,
Advanced Accelerator
,
177lu Dotatate
,
Gep Nets
,
Nets
,
Gastroenteropancreatic Neuroendocrine Tumors
,
Neuroendocrine Tumors
,
Lutetium Lu 177 Dotatate
,
Somatostatin Analog
,
Lutathera
,
Phase 3 Netter 2 Trial
,
2024 Gastrointestinal Cancers Symposium
,
Asco Gi
,
Simron Singh
,
D
,
Bph
,
Sunnybrook Health Sciences Centre
,
vimarsana.com © 2020. All Rights Reserved.